EYPT
Price
$8.77
Change
+$0.51 (+6.17%)
Updated
Jan 6, 03:58 PM (EDT)
52 days until earnings call
SLGL
Price
$1.09
Change
+$0.08 (+7.92%)
Updated
Jan 3 closing price
79 days until earnings call
Ad is loading...

EYPT vs SLGL

Header iconEYPT vs SLGL Comparison
Open Charts EYPT vs SLGLBanner chart's image
EyePoint Pharmaceuticals
Price$8.77
Change+$0.51 (+6.17%)
Volume$1.3K
CapitalizationN/A
Sol-Gel Technologies
Price$1.09
Change+$0.08 (+7.92%)
Volume$195.6K
CapitalizationN/A
EYPT vs SLGL Comparison Chart
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. SLGL commentary
Jan 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and SLGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 06, 2025
Stock price -- (EYPT: $8.26 vs. SLGL: $1.09)
Brand notoriety: EYPT and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 83% vs. SLGL: 33%
Market capitalization -- EYPT: $563.75M vs. SLGL: $30.36M
EYPT [@Biotechnology] is valued at $563.75M. SLGL’s [@Biotechnology] market capitalization is $30.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $389.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileSLGL’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both EYPT and SLGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 5 TA indicator(s) are bullish while SLGL’s TA Score has 6 bullish TA indicator(s).

  • EYPT’s TA Score: 5 bullish, 3 bearish.
  • SLGL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both EYPT and SLGL are a good buy in the short-term.

Price Growth

EYPT (@Biotechnology) experienced а +14.72% price change this week, while SLGL (@Biotechnology) price change was -2.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.35%. For the same industry, the average monthly price growth was +2.18%, and the average quarterly price growth was +7.68%.

Reported Earning Dates

EYPT is expected to report earnings on May 07, 2025.

SLGL is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (+7.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($564M) has a higher market cap than SLGL($30.4M). SLGL YTD gains are higher at: 17.192 vs. EYPT (10.872). SLGL has higher annual earnings (EBITDA): -11.32M vs. EYPT (-102.3M). EYPT has more cash in the bank: 254M vs. SLGL (28.1M). SLGL has less debt than EYPT: SLGL (1.31M) vs EYPT (21.9M). EYPT has higher revenues than SLGL: EYPT (45.7M) vs SLGL (11.7M).
EYPTSLGLEYPT / SLGL
Capitalization564M30.4M1,855%
EBITDA-102.3M-11.32M904%
Gain YTD10.87217.19263%
P/E RatioN/AN/A-
Revenue45.7M11.7M391%
Total Cash254M28.1M904%
Total Debt21.9M1.31M1,677%
FUNDAMENTALS RATINGS
EYPT vs SLGL: Fundamental Ratings
EYPT
SLGL
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
7735
P/E GROWTH RATING
1..100
2098
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLGL's Valuation (54) in the Pharmaceuticals Major industry is in the same range as EYPT (63). This means that SLGL’s stock grew similarly to EYPT’s over the last 12 months.

SLGL's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as EYPT (100). This means that SLGL’s stock grew similarly to EYPT’s over the last 12 months.

SLGL's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as EYPT (98). This means that SLGL’s stock grew similarly to EYPT’s over the last 12 months.

SLGL's Price Growth Rating (35) in the Pharmaceuticals Major industry is somewhat better than the same rating for EYPT (77). This means that SLGL’s stock grew somewhat faster than EYPT’s over the last 12 months.

EYPT's P/E Growth Rating (20) in the Pharmaceuticals Major industry is significantly better than the same rating for SLGL (98). This means that EYPT’s stock grew significantly faster than SLGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EYPTSLGL
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
75%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 18 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Ad is loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCLTX44.310.83
+1.91%
Fidelity Advisor Industrials M
JSPIX24.680.34
+1.40%
Jackson Square Large-Cap Growth Instl
PMJIX11.530.12
+1.05%
PIMCO RAE US Small Instl
JENYX58.090.45
+0.78%
Jensen Quality Growth Y
HEMTX9.270.05
+0.54%
Janus Henderson Emerging Markets T

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+2.86%
LYRA - EYPT
59%
Loosely correlated
-3.70%
ATHE - EYPT
54%
Loosely correlated
+14.21%
GLYC - EYPT
46%
Loosely correlated
+8.50%
OCUL - EYPT
44%
Loosely correlated
+0.23%
CVM - EYPT
37%
Loosely correlated
+3.88%
More

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
+7.39%
TRAW - SLGL
56%
Loosely correlated
-0.12%
RAPT - SLGL
31%
Poorly correlated
+2.45%
RPRX - SLGL
29%
Poorly correlated
+0.19%
EYPT - SLGL
28%
Poorly correlated
+2.86%
GLUE - SLGL
26%
Poorly correlated
+0.84%
More